Healthcare provider profile · identity verified

Justin Brown, NP

Nurse Practitioner · CLARKSVILLE, TX · NPI 1912468109

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	263	90
Amlodipine Besylate	Amlodipine Besylate	214	75
Gabapentin	Gabapentin	199	59
Omeprazole	Omeprazole	167	54
Levothyroxine Sodium	Levothyroxine Sodium	160	46
Albuterol Sulfate Hfa	Albuterol Sulfate	155	42
Lisinopril	Lisinopril	133	51
Losartan Potassium	Losartan Potassium	133	48
Furosemide	Furosemide	128	43
Metformin Hcl	Metformin Hcl	110	46
Pantoprazole Sodium	Pantoprazole Sodium	103	34
Tramadol Hcl	Tramadol Hcl	90	38
Meloxicam	Meloxicam	85	27
Potassium Chloride	Potassium Chloride	84	30
Prednisone	Prednisone	84	50
Montelukast Sodium	Montelukast Sodium	72	23
Carvedilol	Carvedilol	70	20
Ibuprofen	Ibuprofen	68	19
Acetaminophen-Codeine	Acetaminophen With Codeine	62	24
Hydrochlorothiazide	Hydrochlorothiazide	62	26
Metoprolol Succinate	Metoprolol Succinate	62	23
Trazodone Hcl	Trazodone Hcl	62	17
Eliquis	Apixaban	61	11
Tizanidine Hcl	Tizanidine Hcl	61	22
Clopidogrel	Clopidogrel Bisulfate	59	17
Tamsulosin Hcl	Tamsulosin Hcl	58	22
Glimepiride	Glimepiride	57	25
Celecoxib	Celecoxib	54	17
Hydroxyzine Hcl	Hydroxyzine Hcl	54	19
Ozempic	Semaglutide	54	13
Clonazepam	Clonazepam	49	11
Pregabalin	Pregabalin	49	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	18
Azithromycin	Azithromycin	46	35
Hydralazine Hcl	Hydralazine Hcl	46	12
Allopurinol	Allopurinol	45	14
Ropinirole Hcl	Ropinirole Hcl	45	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	11
Rosuvastatin Calcium	Rosuvastatin Calcium	44	18
Mirtazapine	Mirtazapine	43	13
Quetiapine Fumarate	Quetiapine Fumarate	43	13
Sertraline Hcl	Sertraline Hcl	43	12
Fluticasone Propionate	Fluticasone Propionate	41	20
Diclofenac Sodium	Diclofenac Sodium	38	12
Duloxetine Hcl	Duloxetine Hcl	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	14
Pravastatin Sodium	Pravastatin Sodium	36	14
Simvastatin	Simvastatin	36	16
Symbicort	Budesonide/Formoterol Fumarate	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	15
Januvia	Sitagliptin Phosphate	34	suppressed
Meclizine Hcl	Meclizine Hcl	33	14
Clonidine Hcl	Clonidine Hcl	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	25
Metoprolol Tartrate	Metoprolol Tartrate	31	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	24
Baclofen	Baclofen	28	13
Estradiol	Estradiol	28	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Methylprednisolone	Methylprednisolone	28	27
Ezetimibe	Ezetimibe	27	suppressed
Famotidine	Famotidine	26	12
Finasteride	Finasteride	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	12
Alprazolam	Alprazolam	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Torsemide	Torsemide	23	suppressed
Fluconazole	Fluconazole	22	15
Lovastatin	Lovastatin	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	17
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Donepezil Hcl	Donepezil Hcl	19	suppressed
Mupirocin	Mupirocin	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Atenolol	Atenolol	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Jardiance	Empagliflozin	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Nystatin	Nystatin	16	suppressed
Glipizide	Glipizide	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Risperidone	Risperidone	15	suppressed
Temazepam	Temazepam	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Mounjaro	Tirzepatide	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Constulose	Lactulose	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Topiramate	Topiramate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Xeljanz Xr	Tofacitinib Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error